Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis (July/August).
Multiple sclerosis: A distinct disease course for paediatric multiple sclerosis.
Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R(8)ERY.
Gateway to wellness: an occupational therapy collaboration with the national multiple sclerosis society.
Non-Significant Associations Between Measures of Inhibitory Control and Walking While Thinking in Persons with Multiple Sclerosis.
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis.
[Vitamin D and multiple sclerosis : The role for risk of disease and treatment.]
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.
Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.
Comparison of BLADE and conventional T2-TSE sequences for the sagittal visualization of the cervical spinal cord in multiple sclerosis patients - A case report.
Audit on intravenous immunoglobulin (ivig) use in aberdeen royal infirmary neurology department according to 2005 association of british neurologists (abn) guidelines.
Simultaneous optic neuropathy and osmotic demyelinating syndrome in hyperemesis gravidarum.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
A qualitative study of the childbearing experience of women living with multiple sclerosis.
Clinical predictors of an optimal response to natalizumab in multiple sclerosis.
Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial.
Role of Immune Cells in the Course of Central Nervous System Injury: Modulation with Natural Products.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Yield of training exchanges between Europe and Sub-Saharan Africa.
Foot placement patterns of female rollator users with multiple sclerosis in the community.
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
Robert Whytt, Benjamin Franklin, and the first probable case of multiple sclerosis.
Pages
« first
‹ previous
…
279
280
281
282
283
284
285
286
287
…
next ›
last »